Dignitana, a medical technology company with operations based in Dallas, Texas, produces the patented DigniCap Scalp Cooling System to counteract chemotherapy-related hair loss and contribute to improved patient well-being and quality of life. DigniCap was the first scalp cooling system to receive FDA clearance to reduce the likelihood of chemotherapy-induced alopecia in cancer patients with solid tumors. In the pivotal trial DigniCap prevented hair loss in 66.3% of patients with breast cancer receiving adjuvant chemotherapy as published in JAMA February 2017.